Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Compliance is king
Tirzepatide is a dual GLP-1 and GIP agonist, and semaglutide is a GLP-1 agonist
Your clinician sends your prescription and supporting documentation to the Bridge Programs central processor, either electronically or by fax
Your healthcare provider may adjust your dosage of insulin or Ozempic to prevent this side effect
Retatrutide is delivered as a once-weekly subcutaneous injection and is being evaluated across multiple obesity-related conditions in Eli Lillys TRIUMPH Phase 3 clinical trial program, which is the largest registrational trial program ever launched for an anti-obesity medication
Chaudhri OB, Parkinson JR, Kuo YT, Druce MR, Herlihy AH, Bell JD, et al
US$ 21.23
US$ 23.58
US$ 26.55
US$ 26.34
US$ 29.45
US$ 24.93
